18.06.2024
                      
                
                      
                      
                      
                      Real-world data from Germany shows a significant shift in MS treatment strategies—more patients are now starting on early, high-efficacy therapies instead of following the traditional treat-to-target approach. This transition highlights a move towards personalized care that could lead to better long...
                      
                     
                     
                     
                    